Related references
Note: Only part of the references are listed.Sortilin The Mechanistic Link Between Genes, Cholesterol, and Coronary Artery Disease
Adarsh M. Thaker et al.
CARDIOLOGY IN REVIEW (2014)
The Hypercholesterolemia-Risk Gene SORT1 Facilitates PCSK9 Secretion
Camilla Gustafsen et al.
CELL METABOLISM (2014)
Isoquercitrin: Pharmacology, toxicology, and metabolism
Katerina Valentova et al.
FOOD AND CHEMICAL TOXICOLOGY (2014)
Proprotein Convertase Subtilisin Kexin 9 (PCSK9) Inhibitors in the Treatment of Hypercholesterolemia and other Pathologies
Nabil G. Seidah
CURRENT PHARMACEUTICAL DESIGN (2013)
Anti-PCSK9 therapies for the treatment of hypercholesterolemia
Amanda J. Hooper et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2013)
Novel Insights into the Pharmacology of Flavonoids
Barbara Romano et al.
PHYTOTHERAPY RESEARCH (2013)
Proprotein Convertases Subtilisin/Kexin Type 9, an enzyme turned escort protein: Hepatic and extra hepatic functions
Majambu Mbikay et al.
JOURNAL OF DIABETES (2013)
SEC24A deficiency lowers plasma cholesterol through reduced PCSK9 secretion
Xiao-Wei Chen et al.
ELIFE (2013)
Identification and characterization of new gain-of-function mutations in the PCSK9 gene responsible for autosomal dominant hypercholesterolemia
Marianne Abifadel et al.
ATHEROSCLEROSIS (2012)
The novel function of HINFP as a co-activator in sterol-regulated transcription of PCSK9 in HepG2 cells
Hai Li et al.
BIOCHEMICAL JOURNAL (2012)
My road to Damascus: how I converted to the prohormone theory and the proprotein convertases
Michel Chretien
BIOCHEMISTRY AND CELL BIOLOGY (2012)
Hepatic sortilin regulates both apolipoprotein B secretion and LDL catabolism
Alanna Strong et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Leucine 10 allelic variant in signal peptide of PCSK9 increases the LDL cholesterol-lowering effect of statins in patients with familial hypercholesterolaemia
L. Pisciotta et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2012)
Quercetin Up-regulates LDL Receptor Expression in HepG2 Cells
Jiyoung Moon et al.
PHYTOTHERAPY RESEARCH (2012)
Novel Loss-of-Function PCSK9 Variant Is Associated with Low Plasma LDL Cholesterol in a French-Canadian Family and with Impaired Processing and Secretion in Cell Culture
Janice Mayne et al.
CLINICAL CHEMISTRY (2011)
Genetic variation at chromosome 1p13.3 affects sortilin mRNA expression, cellular LDL-uptake and serum LDL levels which translates to the risk of coronary artery disease
Patrick Linsel-Nitschke et al.
ATHEROSCLEROSIS (2010)
Oral bioavailability of quercetin from different quercetin glycosides in dogs
Marianne Reinboth et al.
BRITISH JOURNAL OF NUTRITION (2010)
Sort1, Encoded by the Cardiovascular Risk Locus 1p13.3, Is a Regulator of Hepatic Lipoprotein Export
Mads Kjolby et al.
CELL METABOLISM (2010)
Strong induction of PCSK9 gene expression through HNF1α and SREBP2: mechanism for the resistance to LDL-cholesterol lowering effect of statins in dyslipidemic hamsters
Bin Dong et al.
JOURNAL OF LIPID RESEARCH (2010)
From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus
Kiran Musunuru et al.
NATURE (2010)
The Relationship Between Reduction in Low-Density Lipoprotein Cholesterol by Statins and Reduction in Risk of Cardiovascular Outcomes: An Updated Meta-Analysis
Philippa J. Delahoy et al.
CLINICAL THERAPEUTICS (2009)
Hepatocyte Nuclear Factor 1α Plays a Critical Role in PCSK9 Gene Transcription and Regulation by the Natural Hypocholesterolemic Compound Berberine
Hai Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
PCSK9: a convertase that coordinates LDL catabolism
Jay D. Horton et al.
JOURNAL OF LIPID RESEARCH (2009)
Effects of ezetimibe and/or simvastatin on LDL receptor protein expression and on LDL receptor and HMG-CoA reductase gene expression: A randomized trial in healthy men
Ioanna Gouni-Berthold et al.
ATHEROSCLEROSIS (2008)
Proprotein convertases as therapeutic targets
Michel Chretien et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2008)
Plasma PCSK9 levels are significantly modified by statins and fibrates in humans
Janice Mayne et al.
LIPIDS IN HEALTH AND DISEASE (2008)
Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats
Leonor Rivera et al.
OBESITY (2008)
Red grape juice polyphenols alter cholesterol homeostasis and increase LDL-receptor activity in human cells in vitro
Alberto Davalos et al.
JOURNAL OF NUTRITION (2006)
Missense mutations in the PCSK9 gene are associated with hypocholesterolemia and possibly increased response to statin therapy
KE Berge et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Severe hypercholesterolemia in four British families with the D374Y mutation in the PCSK9 gene - Long-term follow-up and treatment response
RP Naoumova et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9
S Rashid et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Attenuation of lipid peroxidation and hyperlipidemia by quercetin glucoside in the aorta of high cholesterol-fed rabbit
C Kamada et al.
FREE RADICAL RESEARCH (2005)
Statins upregulate PCSK9, the gene encoding the proprotein convertase neural apoptosis-regulated convertase-1 implicated in familial hypercholesterolemia
G Dubuc et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Sterol-responsive element-binding protein (SREBP) 2 down-regulates ATP-binding cassette transporter A1 in vascular endothelial cells - A novel role of SREBP in regulating cholesterol metabolism
LF Zeng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The bioavailability of quercetin in pigs depends on the glycoside moiety and on dietary factors
R Cermak et al.
JOURNAL OF NUTRITION (2003)
Non-high-density lipoprotein cholesterol and cardiovascular disease
V Bittner
CURRENT OPINION IN LIPIDOLOGY (2003)
Mutations in PCSK9 cause autosomal dominant hypercholesterolemia
M Abifadel et al.
NATURE GENETICS (2003)
The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1):: Liver regeneration and neuronal differentiation
NG Seidah et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Intestinal apolipoprotein B secretion is inhibited by the flavonoid quercetin: Potential role of microsomal triglyceride transfer protein and diacylglycerol acyltransferase
A Casaschi et al.
LIPIDS (2002)
Share Paper
